SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 6, 2008 (April 29, 2008)
GUIDED THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation) | 0-22179
(Commission File Number) | 58-2029543
(IRS Employer Identification No.) |
| |
4955 Avalon Ridge Pkwy, Suite 300
Norcross, Georgia
(Address of Principal Executive Offices) | 30071
(Zip Code) |
Registrant's Telephone Number, Including Area Code: (770) 242-8723
(Former Name: SpectRx, Inc.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 7.01. Regulation FD Disclosure.
On May 6, 2008, Guided Therapeutics, Inc. announced it entered into a collaborative option to license and no shop agreement with Konica Minolta Opto, Inc. of Tokyo, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto, which information is incorporated herein by reference.
Table of Contents
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
| Exhibit No. | | Exhibit Description |
| 99.1 | | Press Release, dated May 6, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | GUIDED THERAPEUTICS, INC. |
| |
| | |
/s/ MARK L. FAUPEL
|
| | | By: | | Mark L. Faupel, Ph.D. |
| | | | | President & CEO |
| |
| Date: May 6, 2008. | | | | |
EXHIBIT INDEX
| Exhibit No. | | Exhibit Description |
| 99.1 | | Press Release, dated May 6, 2008 |
